CGI-Clinics Data-driven cancer genome interpretation for personalised cancer treatment
- Coordinator
- Fundacio Institut De Recerca Biomedica (irb Barcelona), Spain
- Runs
- 1 November 2022 to 31 October 2027
- Status
- Running
- EU funding
- €9.6m
- Total cost
- €9.6m
- Partners
- 22 organisations in 8 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101057509
What the project is doing
In the project's own words, from its summary on CORDIS.
CGI-Clinics aims at improving personalised medicine in oncology by optimizing genomic data interpretation (after sequencing and before advising on compatible targeted therapies). Interpretation is a bottleneck for the full deployment and broad accessibility of Next Generation Sequencing (NGS) in cancer management. The project tackles the 3 main hurdles in the interpretation of cancer mutations: it is not systematic, it deals with a majority of variants of unknown significance and it fails to empower patients.
The interpretation of tumor genomic data relies on the work of experts reviewing scattered databases and resources, in a time-consuming process that may lead to suboptimal clinical decisions. CGI-clinics will systematize the interpretation process by integrating relevant public and private databases hospitals in a one-stop shop tool, with the possibility to organize virtual molecular tumor boards co-facilitated by reference hospitals.
Project will have three phases: a setup (assess needs), validation (pilot with the 9 clinical partners) and replication (30 hospitals across EU). It will enable democratization of genomic data interpretation (independent of their size, resources and profiling technology) and provide health economics validation. Relying on a systematic automatic learning platform, GCI-Clinics will increase the share of interpretable variants in tumors (from the current 9-12% to at least 50%), and features that constitute biomarkers of drug response.
The interpretation process is complex for most cancer patients, alienating them from knowledge of their illness. CGI-Clinics will build eduCGI, an app to help them understand the information gained through interpretation of their tumors, facilitating informed discussions with clinicians and sharing their data for research. Ultimately, the project is built to inform policy-makers on cancer management and empower patients.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Fundacio Institut De Recerca Biomedica (irb Barcelona) | Barcelona | Spain | Coordinator |
| European Cancer Patient Coalition | Bruxelles / Brussel | Belgium | Participant |
| Klinikum Der Universitaet Zu Koeln | Koeln | Germany | Participant |
| Universitaetsklinikum Aachen | Aachen | Germany | Participant |
| Ethniko Kentro Erevnas Kai Technologikis Anaptyxis | Thermi Thessaloniki | Greece | Participant |
| Alira Health SL | Barcelona | Spain | Participant |
| Althaia Xarxa Assistencial Universitaria De Manresa Fundacio Privada | Manresa | Spain | Participant |
| Consorcio Para La Explotacion Del Centro Nacional De Analisis Genomico | Barcelona | Spain | Participant |
| Fundacio Centre De Regulacio Genomica | Barcelona | Spain | Participant |
| Fundacio Institut D'investigacio Biomedica De Girona Doctor Josep Trueta | Girona | Spain | Participant |
| Fundacio Privada Institut D'investigacio Oncologica De Vall-Hebron (vhio) | Barcelona | Spain | Participant |
| Fundacion Cientifica De La Asociación Espanola Contra El Cancer | Madrid | Spain | Participant |
| Fundacion Publica Andaluza Progreso Y Salud M.p. | Sevilla | Spain | Third party |
| Institut Catala D'oncologia | Hospitalet de Llobregat | Spain | Third party |
| Servicio Andaluz De Salud | Sevilla | Spain | Participant |
| Alira Health | Paris | France | Third party |
| Centre De Lutte Contre Le Cancer Leon Berard | Lyon | France | Participant |
| Institut Gustave Roussy | Villejuif | France | Participant |
| Alira Health S.r.l | Milano | Italy | Third party |
| European Association for Cancer Research | Nottingham | United Kingdom | Associatedpartner |
| The University of Manchester | Manchester | United Kingdom | Associatedpartner |
| Alira Health Boston LLC | Framingham | United States | Third party |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI